Companies unite to bolster diagnostics for cancer and liver disease
Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…
June 28, 2022 - 2 minutes
Liver disease
Eiger BioPharmaceuticals presents liver study data
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharma company focused on the development of innovative therapies to…
June 28, 2022 - 4 minutes
Is a Treatment for NASH Finally on the Horizon?
Despite several high-profile trial failures in the field, multiple players are getting close to the…
March 2, 2022 - 6 minutes
Engitix Builds Liver Disease Pipeline with Series A and Drug Collaboration
With the close of its Series A round at €48M ($54M), the tissue models company…
January 19, 2022 - 3 minutes
Sponsored
by Medpace
Infographic: The Key Role of Imaging in Clinical Trials
Medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound have…
January 26, 2021 - 2 minutes
German Biotech Raises €11M to Regenerate Liver Damage
Biotech company HepaRegeniX has raised a Series B round that will allow its first…
January 21, 2020 - 2 minutes
Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial
Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M…
December 17, 2019 - 2 minutes
Treating Liver Diseases: Is This Preclinical Model the Solution?
Liver diseases are on the rise. Although many drug candidates are being developed, preclinical toxicity,…
December 4, 2019 - 6 minutes
Can This Cell Therapy Help Fight the NASH Epidemic?
Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD) and…
November 4, 2019 - 7 minutes
€15M to Take Swiss Biotech’s Liver Cirrhosis Treatment to Phase II
Versantis has raised a Series B of €14.6M (CHF 16M) to advance its treatment for…
September 18, 2019 - 3 minutes
Drug for Autoimmune Liver Disease Yields Mixed Results in Hard-to-Treat Patients
Developed by the French biotech Genkyotex, a first-in-class treatment for the liver disease primary biliary…
May 2, 2019 - 2 minutes
Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis
Founded in March this year, Alentis Therapeutics has bagged a Series A round of €11.1M…
April 30, 2019 - 2 minutes
